[go: up one dir, main page]

NO903442D0 - PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION WITH REGULATED BIOLOGICAL AVAILABILITY. - Google Patents

PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION WITH REGULATED BIOLOGICAL AVAILABILITY.

Info

Publication number
NO903442D0
NO903442D0 NO903442A NO903442A NO903442D0 NO 903442 D0 NO903442 D0 NO 903442D0 NO 903442 A NO903442 A NO 903442A NO 903442 A NO903442 A NO 903442A NO 903442 D0 NO903442 D0 NO 903442D0
Authority
NO
Norway
Prior art keywords
preparing
procedure
pharmaceutical preparation
biological availability
regulated biological
Prior art date
Application number
NO903442A
Other languages
Norwegian (no)
Other versions
NO903442L (en
Inventor
Denis Besancon
Jean-Marc Aiache
Alain Dufour
Fabrice Egros
Original Assignee
Delagrange Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delagrange Lab filed Critical Delagrange Lab
Publication of NO903442D0 publication Critical patent/NO903442D0/en
Publication of NO903442L publication Critical patent/NO903442L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO90903442A 1989-08-07 1990-08-06 PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION WITH REGULATED BIOLOGICAL AVAILABILITY. NO903442L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8910605A FR2650502B1 (en) 1989-08-07 1989-08-07 NEW ORAL GALENIC FORM IMPROVING BIOAVAILABILITY

Publications (2)

Publication Number Publication Date
NO903442D0 true NO903442D0 (en) 1990-08-06
NO903442L NO903442L (en) 1991-02-08

Family

ID=9384532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903442A NO903442L (en) 1989-08-07 1990-08-06 PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION WITH REGULATED BIOLOGICAL AVAILABILITY.

Country Status (25)

Country Link
EP (1) EP0412877A1 (en)
JP (1) JPH0377819A (en)
KR (1) KR910004181A (en)
CN (1) CN1049455A (en)
AU (1) AU631235B2 (en)
CA (1) CA2022447A1 (en)
CS (1) CS276556B6 (en)
DD (1) DD297332A5 (en)
DE (1) DE4023136A1 (en)
FI (1) FI903885A7 (en)
FR (1) FR2650502B1 (en)
GB (1) GB2234898A (en)
HU (1) HU204997B (en)
IE (1) IE902629A1 (en)
IL (1) IL95105A0 (en)
IN (1) IN170789B (en)
LU (1) LU87777A1 (en)
MA (1) MA21923A1 (en)
NO (1) NO903442L (en)
NZ (1) NZ234593A (en)
OA (1) OA09301A (en)
PE (1) PE491A1 (en)
PT (1) PT94823A (en)
TN (1) TNSN90111A1 (en)
ZA (1) ZA905886B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE142484T1 (en) * 1992-01-17 1996-09-15 Alfatec Pharma Gmbh SOLID BODY CONTAINING ACTIVE INGREDIENTS WITH A FRAMEWORK OF HYDROPHILIC MACROMOLECLES AND METHOD FOR THE PRODUCTION THEREOF
DE4221880A1 (en) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Solid and liquid solutions of poorly water-soluble drugs
KR20030089147A (en) * 2002-05-16 2003-11-21 슈라펫 주식회사 Water bottle for pet

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE854414C (en) * 1949-04-26 1952-11-04 Dieter Dr Med Ellenbeck Process for the production of injectable solutions of more or less poorly soluble medicaments
GB715874A (en) * 1952-10-03 1954-09-22 Horlicks Ltd A tablet for use in treating peptic ulcers
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3015611A (en) * 1959-08-25 1962-01-02 Nysco Lab Inc Low density whey-bound tablets
GB1063872A (en) * 1962-08-11 1967-03-30 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical compositions
US3594467A (en) * 1968-10-09 1971-07-20 Richardson Merrell Inc Long-lasting troche
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE3250023T (en) * 1981-01-14 1990-03-29
FR2524312B1 (en) * 1982-04-01 1985-10-04 Tech Cuir Centre NOVEL FORMS OF MICRO-ENCAPSULATION OF DRUG SUBSTANCES BY HOMOGENEOUS LAYERS OF NATIVE COLLAGEN
JPS59101423A (en) * 1982-12-02 1984-06-12 Takada Seiyaku Kk Novel solid pharmaceutical preparation of nifedipine
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4670251A (en) * 1984-05-30 1987-06-02 Igene Biotechnology, Inc. Microcrystalline tableting excipient derived from whey
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
IL78017A (en) * 1986-03-03 1989-06-30 Yissum Res Dev Co Sustained release tablets of theophylline
DE3702105A1 (en) * 1987-01-24 1988-08-04 Bayer Ag PARENTERAL SOLUTION
WO1988006457A1 (en) * 1987-03-04 1988-09-07 Nippon Hypox Laboratories Incorporated Medicinal composition containing albumin as carrier and process for its preparation
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
DK179687D0 (en) * 1987-04-08 1987-04-08 Farma Food As PREPARATION
EP0307097B1 (en) * 1987-09-08 1993-06-09 Takeda Chemical Industries, Ltd. Water-insolubilized cytokines

Also Published As

Publication number Publication date
CN1049455A (en) 1991-02-27
HUT55230A (en) 1991-05-28
PE491A1 (en) 1991-01-26
FR2650502B1 (en) 1994-05-27
AU631235B2 (en) 1992-11-19
EP0412877A1 (en) 1991-02-13
CS383890A3 (en) 1992-06-17
FI903885A7 (en) 1991-02-08
GB2234898A (en) 1991-02-20
HU904909D0 (en) 1991-01-28
JPH0377819A (en) 1991-04-03
KR910004181A (en) 1991-03-28
NZ234593A (en) 1993-04-28
DD297332A5 (en) 1992-01-09
DE4023136A1 (en) 1991-02-14
HU204997B (en) 1992-03-30
MA21923A1 (en) 1991-04-01
IL95105A0 (en) 1991-06-10
FI903885A0 (en) 1990-08-06
FR2650502A1 (en) 1991-02-08
GB9017144D0 (en) 1990-09-19
LU87777A1 (en) 1990-12-11
CA2022447A1 (en) 1991-02-08
PT94823A (en) 1991-04-18
IE902629A1 (en) 1991-02-27
ZA905886B (en) 1991-04-24
NO903442L (en) 1991-02-08
CS276556B6 (en) 1992-06-17
IN170789B (en) 1992-05-23
AU6023990A (en) 1991-02-07
TNSN90111A1 (en) 1991-03-05
OA09301A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
NO885641D0 (en) PROCEDURE FOR PREPARING PHARMACEUTICAL PREPARATION.
NO903264D0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION IN THE FORM OF MICROPARTICLES.
NO882103D0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
NO892826L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION FOR AA PREVENT SEXUALLY TRANSFERABLE DISEASES.
IT8820145A0 (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR THEIR PREPARATION.
NO903001D0 (en) PROCEDURE FOR MANUFACTURING PHARMACEUTICAL PREPARATIONS WITH EXTENDED RELEASE.
NO175287C (en) Process for the preparation of an intravenous pharmaceutical preparation
FI903382A0 (en) TOPISKT ANBRINGBARA PHARMACEUTICAL PREPARAT.
NO863670L (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION OF A HYDROPHOBIC MEDICINE.
NO913668D0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION FOR NASAL SUPPLY.
NO871790D0 (en) PROCEDURE FOR THE PREPARATION OF AN ORAL PHARMACEUTICAL PREPARATION.
NO891906D0 (en) PROCEDURE FOR THE PREPARATION OF A RANITIDIN RESIN ADVICE.
NO934897D0 (en) Procedure for Preparing a Pharmaceutical Preparation
NO873562D0 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH IMPROVED SULINDAC ABSORPTION.
NO901232L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
NO870368L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION WITH LONG-TERM EFFECT.
NO883500D0 (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL ACTIVE NITROMETAN.
NO904513L (en) PROCEDURE FOR THE PREPARATION OF A NUTRITION.
FI874382A0 (en) PHARMACEUTICAL PREPARATION.
FI903214A7 (en) Naphthylamino- and naphthyloxy-pyrimidines and related compounds, process for their preparation and their use as dermatological drugs
NO901391D0 (en) PROCEDURE FOR THE PREPARATION OF A 1,8-Naphthyridine Derivative.
NO903513L (en) PROCEDURE FOR THE PREPARATION OF CYCLEIC NEUROKININ A ANTAGONISTS.
NO903442L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION WITH REGULATED BIOLOGICAL AVAILABILITY.
NO913162L (en) PHARMACEUTICAL PREPARATION FOR TONSILLITE TREATMENT.
NO900313D0 (en) PROCEDURE FOR PREPARING A SPICE.